Bristol-Myers Squibb Co
NYSE:BMY
Bristol-Myers Squibb Co
NYSE:BMY
Price:
43.99 USD
0.66%
Market Closed
Updated:
May 4, 2024
Bristol-Myers Squibb Co
Interest Income Expense
|
Bristol-Myers Squibb Co
Interest Income Expense Peer Comparison
Comparables:
JNJ
PFE
MRK
ZTS
LLY
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Interest Income Expense
-$676m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-26%
|
CAGR 10-Years
N/A
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Interest Income Expense
$212m
|
CAGR 3-Years
-29%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Pfizer Inc
NYSE:PFE
|
Interest Income Expense
$1.5B
|
CAGR 3-Years
130%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Merck & Co Inc
NYSE:MRK
|
Interest Income Expense
-$953m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-23%
|
CAGR 10-Years
-10%
|
|
|
Zoetis Inc
NYSE:ZTS
|
Interest Income Expense
-$181m
|
CAGR 3-Years
9%
|
CAGR 5-Years
3%
|
CAGR 10-Years
-4%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Interest Income Expense
-$368m
|
CAGR 3-Years
-133%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-30%
|
See Also
What is Bristol-Myers Squibb Co's Interest Income Expense?
Interest Income Expense
-676m
USD
-676m
USD
Based on the financial report for Mar 31, 2024, Bristol-Myers Squibb Co's Interest Income Expense amounts to -676m USD.
What is Bristol-Myers Squibb Co's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
-26%
-26%
Over the last year, the Interest Income Expense growth was 44%.
You don't have any saved screeners yet
